Dicloxacillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C19H16Cl2N3O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4HZT2V9KX0, chemically known as monosodium (2s,5r,6r)-6-(3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrate, but more generally known as dicloxacillin sodium, which bears US NIH Compound Identifier 6098. European Medicines Agency schedules dicloxacillin sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07099MIG. Most nations, for tariff purposes, schedule dicloxacillin sodium under HS 29411090. As of Q4 2014, DICLOXACILLIN SODIUM remains US FDA's Preferred Term for this commodity. Dicloxacillin sodium bears US NLM identifiers UMLS ID C0887422 and NCI Concept Code C47985. SMILES: CC1C(C(NO1)C2C(CCCC2CL)CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].